The global mouth ulcer treatment market size is expected to reach USD 2.06 billion by 2030, registering a CAGR of 3.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing geriatric population and rising awareness towards oral hygiene are among the key trends stimulating market growth. The growing global geriatric population is poised to trigger the number of cases of ulcers. As per the findings of the United Nations Organization (UNO), between 2015 and 2022, the population base of age 60 years and over is expected to grow from 12% to 22%. With the upswing in the demand for denture fittings in this population, a rise in the incidences of improper fittings and deficiency of vitamin B & folic acid is anticipated. Such incidents can lead to mouth ulcers.
Newly fitted dentures take some time to adjust. During the procedure, the inner area of the mouth remains moist for a certain period. Such conditions cause fungal infections leading to ulcers. The older population often suffers from such conditions, due to which they are prone to oral problems. In addition, a deficiency of vitamins is a common phenomenon observed among the geriatric population, which also increases the probability of suffering from mouth ulcers.
Rising awareness regarding oral hygiene in developing countries is also estimated to drive the market growth over the forecast period. Campaigns on oral hygiene in rural areas of developing countries are working in favor of the market. For instance, every year, Colgate-Palmolive Company conducts an oral health month in rural areas of India to impart awareness regarding oral hygiene. Such initiatives are expected to encourage people to take up necessary treatments. Furthermore, a rise in tobacco usage in countries such as the UK and Mexico is projected to boost the rate of mouth ulcers, thereby benefitting the growth of the market.
Request a free sample copy or view report summary: Mouth Ulcer Treatment Market Report
Based on drug class, the analgesics & corticosteroids segment accounted for the largest revenue share in 2022 and is also expected to grow at the fastest CAGR over the forecast period owing to the increasing prescription rate of painkillers across the world
Based on formulation, the gels segment accounted for the largest revenue share of 37.2% in 2022. Ease of application, fast treatment, and pain relief are some of the features of gel-based treatment responsible for the growth of the segment over the forecast period
The sprays segment is expected to grow at the fastest CAGR of 5.0% over the forecast period owing to its increasing adoption amongst children and elderly population for its convenient application
In 2022, North America dominated with a revenue share of 35.2% owing to the well-established pharmaceutical industry in the region. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR of 5.0% over the forecast period due to the increasing awareness of the long-term effects of mouth ulcers and the increasing availability of various types of mouth ulcer treatment options
Grand View Research has segmented the global mouth ulcer treatment market based on drug class, formulation, and region:
Mouth Ulcer Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
Antimicrobial
Antihistamine
Analgesics & Corticosteroids
Others
Mouth Ulcer Treatment Formulation Outlook (Revenue, USD Million, 2018 - 2030)
Sprays
Mouthwash
Gels
Lozenges
Mouth Ulcer Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Mouth Ulcer Treatment Market
Blistex, Inc.
Church & Dwight Co., Inc.
3M
Colgate- Palmolive Company
GlaxoSmithKline, Plc
Bristol Myers Squibb Company
Pfizer, Inc.
"The quality of research they have done for us has been excellent..."